NVAX

Novavax, Inc.

9.69 USD

Last updated Oct 24, 01:12 UTC

Yesterday HIGH

$10.86

Yesterday LOW

$9.56

52w HIGH

$13.38

52w LOW

$6.2

EPS

-0.32

PE

-30.28

Next Earnings

Nov 5, 2026

Overview News Unusual Options Flow Government Trades Fundamentals

Novavax, Inc. stock is down -8.15% since 30 days ago. The next earnings date is Nov 5, 2026. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 29.03% of the previous 30 October’s closed higher than September. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time	Expiration Date	Strike Price	Trade Type	Size	Open Interest

22 Oct 15:17	15 Jan, 2027	10.00	CALL	200	14437
22 Oct 16:50	15 Jan, 2027	11.00	CALL	400	1110
22 Oct 17:11	16 Apr, 2027	10.00	CALL	1173	1696
22 Oct 17:36	15 Jan, 2027	11.00	CALL	1100	1110
22 Oct 17:55	15 Jan, 2027	11.00	CALL	1000	1110
22 Oct 18:35	20 Nov, 2026	11.00	CALL	650	2085
22 Oct 18:50	20 Nov, 2026	11.00	CALL	350	2085
23 Oct 18:23	17 Dec, 2027	10.00	CALL	100	2139
23 Oct 19:26	30 Oct, 2026	9.50	PUT	1246	264
23 Oct 19:50	16 Apr, 2027	8.00	CALL	141	190

Advanced Data Unlock

Benzinga Newsdesk

Tue Sep 1, 2026

Watching Novavax; Shares Trading Higher In The Session, Traders Circulate Unconfirmed Rumor Suggesting Clinical Data Show That Matrix-M Has A Favorable Safety Profile With Mostly Mild-To-Moderate, Self-Limiting Side Effects
Henry Khederian

Tue Sep 1, 2026

What's Going On With Novavax Stock?

Shares of Novavax are trading higher Tuesday. The stock is up over 30% over the trailing month as traders weigh updated autumn vaccine authorizations against the company's broader strategic pivot toward licensing and cost-structure optimization.
Henry Khederian

Mon Aug 31, 2026

Novavax Stock Climbs Monday: What's Going On?

Shares of Novavax are trading higher Monday, extending its 30% monthly gains on COVID-19 vaccine approvals and broader biotech strength.
Avi Kapoor

Mon Aug 31, 2026

Ascendis Pharma, Science Applications International And Other Big Stocks Moving Higher On Monday

U.S. stocks were lower, with the Dow Jones index falling around 400 points on Monday. Shares of Ascendis Pharma A/S (NASDAQ:ASND) rose sharply on Monday. On Sunday, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Benzinga Newsdesk

Fri Aug 28, 2026

Novavax's Partners Receive Approvals For Nuvaxovid Formulation To Target SARS-CoV-2 XFG Variant

Novavax, Inc.'s (NASDAQ:NVAX) partners have received approvals for the Nuvaxovid™ formulation to target the SARS-CoV-2 XFG variant for the 2026-2027 vaccination season in major markets including the U.S., European
Benzinga News-desk

Thu Aug 27, 2026

QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax

FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligibility for adults 65+ and those with high-risk conditions.
Henry Khederian

Tue Aug 25, 2026

Novavax Stock Rallies Tuesday: What's Happening?

Shares of Novavax are trading higher Tuesday morning as buying interest continues across late-stage vaccine developers.
Mohd Haider

Thu Aug 20, 2026

Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's Why

Recursion, Novavax and Crispr Therapeutics slip in premarket trading after surging Wednesday on positive cancer therapy trial results.
Henry Khederian

Wed Aug 19, 2026

Novavax Stock Moves Higher Wednesday: What's Driving the Action?

Shares of Novavax Inc (NASDAQ: NVAX) are trading higher Wednesday. The move comes as a major clinical victory in the oncology space generated widespread momentum across vaccine developers.
Benzinga News-desk

Mon Aug 10, 2026

Trump Says Administration Recognizing Childhood Vaccine Recommendations For Only 11 Core Vaccinations; Hepatitis B, COVID-19, Influenza No Longer Recommended For All Children

https://youtu.be/H_RititNE8U